transmiss
virus
biolog
materi
great
concern
mani
research
manag
lab
anim
facil
ampl
confound
effect
transmiss
research
viral
infect
experiment
anim
often
absenc
clinic
diseas
even
greater
concern
outbreak
infect
among
laboratori
worker
zoonot
agent
lymphotroph
choriomening
viru
lcmv
traceabl
contamin
biolog
materi
transplant
anim
biosecur
tenet
mani
research
organ
requir
screen
viral
agent
cell
line
tumor
sera
biolog
implant
inocul
anim
model
feder
also
dictat
monoclon
antibodi
mab
biotechnolog
product
deriv
tissu
cell
line
anim
origin
demonstr
free
viral
contamin
use
therapeut
diagnost
purpos
recent
mous
antibodi
product
map
test
primari
method
screen
virus
murin
tabl
applic
modern
molecular
biolog
method
purpos
present
certain
advantag
articl
compar
map
test
polymeras
chain
reaction
pcr
detect
viral
agent
although
discuss
concentr
map
test
particular
concept
present
paper
also
applic
rat
hamster
antibodi
product
rap
hap
test
row
et
first
develop
map
test
simpl
equal
sensit
altern
tissu
cultur
detect
polyoma
viru
other
sinc
appli
simplifi
detect
typic
test
involv
inocul
mice
multipl
rout
test
articl
hold
isol
minimum
four
research
collect
serum
sampl
anim
test
virusspecif
antibodi
use
enzymelink
immunosorb
elisa
indirect
fluoresc
antibodi
ifa
hemagglutin
inhibit
hai
assay
detect
virusspecif
antibodi
indic
presenc
viru
test
articl
detect
lactat
viru
ldv
effect
antibodi
test
exist
consist
screen
serum
elev
level
enzym
lactat
dehydrogenas
literatur
contain
number
survey
demonstr
import
map
test
screen
viral
agent
tabl
ldv
seem
present
frequent
contamin
although
reoviru
lcmv
minut
viru
mice
mvm
mous
hepat
viru
mhv
also
detect
regularli
gener
trend
last
three
decad
seem
toward
fewer
case
contamin
biolog
materi
test
viral
agent
interest
decreas
preval
coincid
reduc
rate
viral
infect
anim
coloni
result
stricter
biosecur
measur
throughout
laboratori
anim
includ
map
test
materi
molecular
biolog
method
permit
assay
test
articl
directli
presenc
specif
nucleic
acid
contamin
infecti
agent
oppos
indirectli
test
elicit
immun
respons
pcr
one
power
flexibl
molecular
techniqu
recent
year
appli
toward
replac
map
basic
principl
behind
pcr
vitro
amplif
particular
dna
sequenc
eg
viral
gene
sampl
easili
detect
level
use
thermost
dna
polymeras
enzym
usual
taq
polymeras
oligonucleotid
primer
specif
target
interest
computercontrol
thermocycl
precis
manipul
reaction
fig
cycl
pcr
newli
synthes
dna
molecul
may
act
templat
amplif
result
process
exponenti
increas
number
target
sequenc
potenti
creat
billion
copi
also
refer
amplicon
singl
dna
templat
subsequ
detect
pcr
product
involv
perform
gel
electrophoresi
aliquot
reaction
mixtur
stain
visual
dna
molecul
appear
discret
band
separ
basi
length
allow
identif
pcr
product
target
sequenc
present
origin
sampl
pcr
amplifi
dna
molecul
one
detect
virus
rna
genom
tabl
first
perform
reversetranscript
rt
reaction
rna
test
articl
creat
singlestrand
complementari
dna
cdna
molecul
use
templat
rtpcr
involv
either
twostep
reaction
gener
cdna
transfer
aliquot
pcr
mixtur
singl
step
enzym
requir
reaction
present
tube
research
adapt
numer
variat
pcr
method
detect
infecti
agent
perform
dna
templat
well
rna
templat
rt
step
recent
develop
particularli
use
diagnost
applic
fluorogen
also
known
taqman
pcr
make
use
addit
dyelabel
oligonucleotid
probe
specif
hybrid
pcr
product
fig
amplif
progress
probe
bind
pcr
product
templat
undergo
digest
polymeras
enzym
releas
detect
fluoresc
signal
may
read
fluoromet
complet
reaction
monitor
realtim
cours
reaction
special
thermocycl
permit
quantif
start
templat
product
detect
fluoresc
permit
high
level
sensit
greatli
simplifi
postpcr
analysi
lend
plate
format
allow
use
semiautom
autom
procedur
throughput
need
requir
appropri
equip
laboratori
support
perform
pcr
detect
murin
virus
see
laboratori
requir
use
assay
publish
literatur
develop
premis
although
sever
commerci
provid
servic
exist
tabl
cost
vari
provid
also
depend
number
agent
interest
test
gener
differ
panel
assay
avail
depend
custom
need
instanc
charl
river
laboratori
crl
offer
essenti
panel
virus
comprehens
panel
virus
although
assay
individu
virus
also
avail
viru
pcr
assay
panel
may
also
includ
test
mycoplasma
common
bacteri
contamin
tumor
cell
anim
facil
train
personnel
requir
map
test
gener
alreadi
present
organ
type
anim
experiment
potenti
infect
advis
conduct
map
test
facil
separ
area
use
hous
anim
studi
map
test
requir
immunocompet
mice
free
antibodi
viral
pathogen
one
must
take
addit
precaut
use
steril
microisol
unit
perform
anim
manipul
biosafeti
cabinet
avoid
infect
virus
potenti
test
articl
prevent
infect
anim
facil
detect
antibodi
enzym
level
case
ldv
specif
agent
question
requir
access
serolog
test
laboratori
pcr
test
requir
personnel
train
molecular
biolog
techniqu
special
equip
includ
stillair
work
hood
sampl
process
thermal
cycler
gel
electrophoresi
equip
andor
fluorometr
detect
system
prevent
falseposit
result
due
contamin
pcr
templat
reagent
prepar
sampl
process
pcr
amplificationproduct
detect
take
place
separ
laboratori
ideal
personnel
laboratoryspecif
gown
equip
workflow
proceed
clean
dirti
area
prevent
contamin
reagent
sampl
amplicon
gener
amplif
area
primari
advantag
use
pcr
panel
reduct
time
submiss
sampl
report
result
map
test
protocol
requir
minimum
day
inocul
allow
anim
mount
detect
immun
respons
specimen
prepar
serolog
test
contribut
addit
time
total
requir
method
comparison
pcr
allow
process
test
articl
analysi
result
period
short
one
two
day
although
number
sampl
analyz
resourc
avail
may
increas
turnaround
time
gener
pcr
result
becom
avail
less
one
week
standard
map
test
protocol
call
minimum
ml
test
materi
enough
inocul
five
mice
ml
intraperiton
ml
intranas
ml
oral
inocul
anoth
five
mice
similarli
dilut
test
materi
one
dilut
smaller
amount
materi
use
although
may
diminish
sensit
test
research
deal
limit
quantiti
test
articl
valuabl
sampl
viru
pcr
panel
may
prefer
method
test
assay
perform
crl
requir
extract
reversetranscrib
dna
templat
per
reaction
gener
test
articl
suffici
per
panel
although
recommend
submiss
duplic
sampl
permit
confirmatori
test
bind
capac
purif
column
use
nucleic
acid
extract
limit
number
cell
mass
tissu
cell
mg
tissu
may
process
pcr
test
one
seriou
concern
use
pcr
diagnost
capac
high
sensit
make
suscept
falseposit
result
contamin
templat
three
potenti
sourc
contamin
sampl
experiment
materi
posit
control
pcr
product
gener
previou
reaction
target
howev
adequ
precaut
control
minim
contamin
detect
erron
result
report
effect
method
contamin
prevent
separ
task
reagent
prepar
sampl
prepar
pcr
amplif
analysi
differ
lab
mainten
strict
workflow
procedur
clean
dirti
area
must
transfer
area
roomdesign
equip
pipettor
sampl
rack
etc
gown
personnel
manipul
posit
control
templat
amplif
lab
possibl
prepar
facil
separ
routin
sampl
extract
qualiti
control
track
program
sampl
extract
pcr
reagent
also
place
assign
lot
number
reagent
prepar
identif
aliquot
use
help
trace
sourc
contamin
event
occur
personnel
use
singleus
aliquot
whenev
possibl
monitor
contamin
reagent
personnel
alway
perform
neg
control
reaction
strongli
posit
test
articl
present
potenti
sourc
contamin
sampl
prepar
process
step
import
handl
sampl
individu
one
tube
open
whenev
possibl
stillair
hood
pcr
workstat
help
avoid
transfer
aerosol
sampl
practic
recommend
submiss
duplic
sampl
eg
two
aliquot
test
articl
pcr
panel
test
one
aliquot
undergo
initi
test
event
posit
result
untouch
retain
sampl
undergo
extract
retest
posit
assay
includ
control
confirm
posit
result
carryov
contamin
pcr
product
previou
reaction
particular
concern
especi
analyz
pcr
product
gel
one
prevent
combin
includ
enzym
uracil
nglycosylas
ung
substitut
nucleotid
deoxyuracil
du
thymin
pcr
master
altern
nucleotid
becom
incorpor
pcr
product
cours
reaction
subsequ
reaction
brief
incub
pcr
allow
ung
degrad
dna
molecul
contain
product
potenti
carri
earlier
unavail
amplif
legitim
templat
contain
thymin
unaffect
ung
inactiv
pcr
begin
serolog
assay
may
also
give
falseposit
result
numer
reason
includ
incomplet
purifi
antigen
crossreact
particular
difficulti
interpret
map
test
result
may
aris
antibodi
gener
actual
biolog
materi
test
react
cell
cultur
control
materi
use
prepar
elisa
antigen
although
noninfecti
viru
particl
elicit
immun
respons
high
antibodi
titer
like
develop
activ
viral
requir
presenc
adequ
number
infecti
viral
particl
map
test
success
mani
virus
becom
noninfecti
chang
temperatur
ph
possibl
result
inactiv
storag
transport
prepar
test
articl
contrast
pcr
test
detect
infecti
noninfecti
viru
particl
alik
provid
sampl
mishandl
extent
nucleic
acid
degrad
pcr
assay
may
subject
inhibit
substanc
present
test
articl
complet
remov
nucleic
acid
extract
procedur
lead
falseneg
result
possibl
detect
inhibit
perform
separ
spike
control
assay
limit
copi
number
anoth
templat
ad
along
extract
sampl
pcr
mixtur
independ
assay
evalu
assay
posit
result
indic
absenc
pcr
inhibitor
degrad
nucleic
acid
ineffici
recoveri
extract
test
articl
also
give
falseneg
result
one
control
ad
anoth
exogen
templat
earli
stage
sampl
prepar
test
final
tna
extract
templat
nucleic
acid
recoveri
control
may
also
act
spike
control
pcr
inhibitor
although
separ
two
control
simplifi
troubleshoot
fail
assay
summari
publish
detect
sensit
number
pcr
assay
along
sensit
data
appear
tabl
direct
comparison
pcr
assay
list
map
test
pcr
assay
sensit
map
test
equal
sensit
choic
anim
use
influenc
sensit
map
test
virus
elicit
differ
level
antibodi
respons
particular
mous
limit
detect
among
pcr
assay
vari
greatli
pcr
technolog
primer
design
amplicon
size
cycl
paramet
pcr
reagent
nucleic
acid
extract
procedur
furthermor
comparison
differ
pcr
assay
agent
difficult
make
base
indirect
viru
titer
method
infect
assay
sensit
titer
method
highli
depend
number
variabl
includ
viru
strain
host
anim
cell
line
suscept
ratio
infect
noninfect
viru
particl
particular
viru
stock
test
cultur
techniqu
map
pcr
assay
sensit
known
viru
strain
may
capabl
detect
diverg
newli
emerg
strain
recent
case
serolog
assay
mvm
mvm
elisa
detect
close
relat
mous
parvoviru
mpv
differ
respect
viru
capsid
similarli
pcr
primer
probe
must
target
genet
sequenc
highli
conserv
among
strain
agent
test
agent
diverg
sequenc
strain
subspeci
may
requir
multipl
degener
pcr
primer
within
reaction
mixtur
may
requir
addit
assay
instanc
absenc
highli
conserv
sequenc
hantavirus
led
us
design
separ
assay
hantaan
seoul
strain
widespread
use
antibodi
product
test
past
decad
led
broad
accept
method
choic
detect
rodent
virus
biolog
materi
use
studi
follow
good
laboratori
practic
glp
well
product
human
use
biotechnolog
product
deriv
cell
line
mab
fda
guidelin
specif
mention
antibodi
product
one
also
use
test
least
equival
sensit
pcr
adequ
valid
method
perform
respect
aspect
sensit
select
specif
reproduc
valid
experi
must
take
place
valid
equip
qualitycontrol
reagent
use
document
standard
oper
procedur
appropri
document
data
regular
review
qualiti
assuranceregulatori
affair
depart
also
necessari
compon
process
distinct
advantag
pcr
panel
test
replac
animalbas
test
seri
vitro
assay
consist
rs
human
experiment
techniqu
reduct
replac
refin
crl
standard
map
test
procedur
involv
inocul
mice
test
articl
dilut
test
articl
anoth
mice
neg
control
articl
pcr
use
thu
avoid
use
anim
per
test
articl
along
associ
distress
screen
biolog
materi
infecti
agent
use
vivo
experiment
import
precaut
research
integr
although
tradit
method
accomplish
serolog
map
test
use
modern
molecular
biolog
techniqu
pcr
permit
test
done
much
rapidli
greater
sensit
high
reliabl
provid
adequ
control
implement
